Analyze Diet

Topic:Prostaglandins

Prostaglandins are lipid compounds derived from fatty acids that are present in various tissues of horses. They are involved in a wide range of physiological processes, including the regulation of inflammation, blood flow, and reproductive functions. In equine medicine, prostaglandins are often studied for their role in modulating inflammatory responses and their potential therapeutic applications. These compounds can influence pain perception and are involved in processes such as parturition and the estrous cycle in mares. This page collects peer-reviewed research studies and scholarly articles that explore the synthesis, function, and clinical applications of prostaglandins in equine health.
Comparison of the effects of prostacyclin (PGI2), prostaglandin E1 and D2 on platelet aggregation in different species.
Prostaglandins    September 1, 1978   Volume 16, Issue 3 373-388 doi: 10.1016/0090-6980(78)90216-2
Whittle BJ, Moncada S, Vane JR.The activity of prostacyclin (PGI2), PGE1 or PGD2 as inhibitors of platelet aggregation in plasma from human, dog, rabbit, rat, sheep and horse was investigated. Prostacyclin was the most potent inhibitor in all species. PGD2 was a weak inhibitor in dog, rabbit and rat plasma whereas PGE1 and prostacyclin were highly active. Theophylline or dipyridamole potentiated the inhibition of human platelet aggregation by prostacyclin, PGE1 or PGD2. Compound N-0164 abolished the inhibition by PGD2 of human platelet aggregation but did not inhibit the effects of PGE1 or prostacyclin. The results suggest ...
Foetal and maternal plasma concentrations of 13, 14-dihydro-15-oxo-prostaglandin F in the mare during late pregnancy and at parturition.
The Journal of endocrinology    August 1, 1978   Volume 78, Issue 2 201-215 doi: 10.1677/joe.0.0780201
Barnes RJ, Comline RS, Jeffcott LB, Mitchell MD, Rossdale PD, Silver M.The concentrations of 13, 14-dihydro-15-oxo-prostaglandin F(PGFM), the stable metabolite of prostaglandin F, were measured in the plasma of catheterized mares and foetuses and non-catheterized thoroughbred mares and ponies during the last months of gestation. The plasma concentration of PGFM increased gradually towards term in all groups of animals. During the operation for insertion of catheters, maternal and foetal concentrations of PGFM were high, but the values fell to basal levels 24--48 h after the operation. It was found the preoperative starvation (24 h) led to a rise in the concentrat...
Pregnant mare’s serum gonadotropin. IV. Induction of premature labor by pregnant mare’s serum gonadotropin and its prevention by using clomiphene or indomethacin.
Fertility and sterility    June 1, 1978   Volume 29, Issue 6 640-642 
Basu R, Chatterjee A.The administration of pregnant mare's serum gonadotropin (PMSG), 30 IU on day 18 of pregnancy, resulted in premature labor in rats. However, this abortifacient efficacy of PMSG was not demonstrable when a simultaneous injection of progesterone, clomiphene, or indomethacin was scheduled, thus suggesting that the action of PMSG is medicated by the estrogen-stimulated release of prostaglandin. The termination of pseudopregnancy in bilaterally hysterectomized rats by PMSG and its reversal by indomethacin revealed that the inhibition of luteal function by PMSG does not require the presence of a ute...
Pregnant mare’s serum gonadotropin: V. Indomethacin or cortisone and the reversal of antifertility efficacy of pregnant mare’s serum gonadotropin.
Contraception    June 1, 1978   Volume 17, Issue 6 547-552 doi: 10.1016/s0010-7824(78)80006-7
Gupta T, Chatterjee A.Pregnant mare's serum gonadotropin (PMSG) of 10 IU on day 5 of pregnancy induced luteal demise and consequently an absolute resorption of fetuses and placentae resulted on day 16 of pregnancy. Simultaneous regimen of PMSG and indomethacin or cortisone was found to be consistently effective in preventing the luteolytic effect of PMSG. The growth of the fetuses, placentae as well as corpora lutea was found to be parallel to controls. Similarly, shortening of the duration of pseudopregnancy to 10--12 days in the bilaterally hysterectomized rat by PMSG and its retaining the normal duration of 18--...
[Clinical experiences with a prostaglandin F2alpha-analog (Equimate) in the mare].
Berliner und Munchener tierarztliche Wochenschrift    February 19, 1978   Volume 91, Issue 4 61-64 
Leidl W, Stolla R, Rockel P, Mayr B, Färber A.No abstract available
[New, effective luteolytic prostaglandins. Observations in cattle, sheep, and horse. Preliminary report].
Berliner und Munchener tierarztliche Wochenschrift    December 15, 1977   Volume 90, Issue 24 477-479 
Seeger K, Seidel L.No abstract available
[Uterine motility in vitro induced by PGF2alpha in cattle and horses in various stages of pregnancy].
Bollettino della Societa italiana di biologia sperimentale    November 15, 1977   Volume 53, Issue 21 1964-1970 
Minoia P, Mitolo-Chieppa D, Renna G, Lograno M.No abstract available
A critical review of current methods for induction of parturition in the mare.
Equine veterinary journal    October 1, 1977   Volume 9, Issue 4 208-215 doi: 10.1111/j.2042-3306.1977.tb04033.x
Jeffcott LB, Rossdale PD.The efficacy and safety of oxytocin, dexamethasone and prostaglandin, used alone or in combination as inducing agents, are discussed. It is contended that insufficient evidence exists to support the routine application of any of these methods in practice. Oxytocin has been the most widely used and it is claimed by some to be free from side effects. However, the synthetic prostaglandin analogue, fluprostenol, seems to pose the least risk to the foetus and dexamethasone appears to be either ineffective, or too dangerous to use at all. The main indications for induced foaling are managerial conve...
Pharmacologic and toxicologic study of prostaglandin F2alpha in mares.
American journal of veterinary research    September 1, 1977   Volume 38, Issue 9 1445-1452 
Goyings LS, Lauderdale JW, McConnell RF.No abstract available
Nonsteroidal anti-inflammatory drugs: a review. New applications in hypersensitivity reactions of cattle and horses. Chand N, Eyre P.Nonsteroidal anti-inflammatory drugs inhibit the biosynthesis of kinins and prostaglandins and stabilize leukocyte lysosomal membranes. Nonsteroidal anti-inflammatory drugs also weakly block the biosynthesis of histamine and serotonin, and pharmacologically antagonize kinins, prostaglandins and slow-reacting substance of anaphylaxis. Nonsteroidal anti-inflammatory drugs effectively control both cardiovascular and respiratory manifestations of hypersensitivity in cattle and horses. This, coupled with the contrasting lack of effectiveness of "antiamine" drugs, suggests that bio-amines such as hi...
Serum luteinizing hormone, estrus, and ovulation in mares following treatment with prostaglandin F2alpha and gonadotropin-releasing hormone.
American journal of veterinary research    May 1, 1977   Volume 38, Issue 5 649-653 
Oxender WD, Noden PA, Pratt MC.No abstract available
Effect of prostaglandin analogue on progesterone-treated pony mares during early pregnancy.
Equine veterinary journal    April 1, 1977   Volume 9, Issue 2 92-95 doi: 10.1111/j.2042-3306.1977.tb03992.x
Allen WE.Seven Welsh pony mares (9 pregnancies) received either 50 mg, 100 mg or 150 mg progesterone on alternate days, starting on day 21 of gestation. All but 2 pregnancies failed following prostaglandin administration on day 27. Although both mares were receiving the 150 mg progesterone dose rate, this treatment was not consistently successful in preventing pregnancy failure after prostaglandin administration.
Estrus, ovulation and conception following synchronization with progesterone, prostaglandin F2alpha and human chorionic gonadotropin in pony mares.
Journal of animal science    March 1, 1977   Volume 44, Issue 3 431-437 doi: 10.2527/jas1977.443431x
Holtan DW, Douglas RH, Ginther OJ.No abstract available
Prostaglandin F2alpha specific binding in equine corpora lutea.
Prostaglandins    March 1, 1977   Volume 13, Issue 3 553-564 doi: 10.1016/0090-6980(77)90032-6
Kimball FA, Wyngarden LJ.Preliminary studies indicate the presence of PGF2alpha specific binding sites in membrane fractions prepared from equine corpora lutea. The equilibrium binding data indicate an apparent dissociation constant of 3.2 X 10(-9)M and the concentration of binding sites of -0.1 pmoles/mg membrane protein. Competition of several natural prostaglandins for equine luteal PGF2alpha specific binding sites indicates specificity for the 9alpha-hydroxyl moiety and the 5,6-cis doublebond. Significant increases in relative binding affinities were demonstrated for PGF2alpha analogs with a phenyl ring introduced...
[Clinical findings with prostaglandin F2 alpha. Use of ICI 81008 fluprostenol (equimate) for estrous cycle regulation in the mare].
Tierarztliche Praxis    January 1, 1977   Volume 5, Issue 4 475-480 
Klug E, Merkt H, Günzel A.No abstract available
Prostaglandin F2alpha treatment of cyclic dysfunction in mares.
The Canadian veterinary journal = La revue veterinaire canadienne    December 1, 1976   Volume 17, Issue 12 301-307 
Mitchell D, de Gannes R, Sugden EA.THE ABILITY OF PROSTAGLANDIN (PG)F2a and its synthetic analogues to induce luteolysis in the mare has been adequately demonstrated (3, 6). This luteolytic effect has been utilized in the treatment of several forms of cyclic dysfunction encountered in horse breeding. It has been shown that a high proportion of Thoroughbred mares with persistent luteal function (prolonged diestrus) treated with PCF2a analogues will come into estrus within four days of treatment and that they will ovulate normally (4, 10). Thus PG treatment of mares which exhibit aberrant estrous cycles during the breeding season...
Summary of the effect of prostalene, a new synthetic prostaglandin, on the breeding efficiency of mares.
Veterinary medicine, small animal clinician : VM, SAC    November 1, 1976   Volume 71, Issue 11 1616-1623 
Averkin G, Schiltz R.No abstract available
Effects of repeated daily injections of prostaglandin F2alpha on ovaries in mares.
Prostaglandins    November 1, 1976   Volume 12, Issue 5 881-894 doi: 10.1016/0090-6980(76)90061-7
Douglas RH, Ginther OJ.In experiment 1, seven groups of pony mares (2 or 3/group) were given either no injections (controls), or 5 (5X) or 10 (10X) daily subcutaneous (SC) injections of 1.25 mg PGF2alpha beginning on days 1, 7 or 13 post-ovulation. Compared to controls (24.5 days), the interovulatory interval was longer (P less than ..05) for day 7, 10X (33.5 days) and day 13, 10X mares (49.0 days) but was not different for the remaining groups. In experiment 2, nine groups of pony mares (4/group) were given either no injections (controls) or 1 (1X) or 10 (10X) daily SC injections of 1.25 mg PGF2alpha beginning on d...
Intrauterine use of prostagladin F2 alpha in mares.
The Veterinary record    September 11, 1976   Volume 99, Issue 11 212-213 doi: 10.1136/vr.99.11.212
Bowen JM.No abstract available
Prostaglandins in the mare.
The Veterinary record    August 21, 1976   Volume 99, Issue 8 153-154 doi: 10.1136/vr.99.8.153
No abstract available
The use of synthetic prostaglandin analogue to induce oestrus in mares.
Australian veterinary journal    August 1, 1976   Volume 52, Issue 8 345-348 doi: 10.1111/j.1751-0813.1976.tb09484.x
Shepherd GE, Findlay JK, Cooper MJ, Allen WR.A clinical trial involving 359 mares was conducted to ascertain the clinical value of a synthetic prostaglandin analogue (fluprostenol, ICI-81,008) structurally related to PGF2oc for treating mares in prolonged dioestrus. Some 263 mares (73.3%) displayed oestrus within 5 days of a first intramuscular injection of 250 mug fluprostenol and, of those mares later examined for pregnancy, 108 (40%) were found to have conceived during the first induced oestrus. A further 21 mares (8%) cycled normally and conceived to services during the second oestrus. Most (80.3%) of the plasma samples obtained from...
Prostaglandins in the mare.
The Veterinary record    July 31, 1976   Volume 99, Issue 5 93 doi: 10.1136/vr.99.5.93
Brook D.No abstract available
Foaling induced by a synthetic prostaglandin analogue (fluprostenol).
The Veterinary record    July 10, 1976   Volume 99, Issue 2 26-28 doi: 10.1136/vr.99.2.26
Rossdale Pd, Jeffcott LB, Allen WR.No abstract available
Fluprostenol in mares: clinical trials for the treatment of infertility.
The Veterinary record    June 26, 1976   Volume 98, Issue 26 523-525 doi: 10.1136/vr.98.26.523
Cooper MJ.Fluprostenol (ICI 81,008) is a 16-aryloxyprostaglandin, structurally related to PGF2alpha. It is a highly potent luteolytic agent, being effective in thoroughbred mares at a single intramuscular dose of 250 mug and having a wide margin of safety in this species. A total of 941 mares have been treated with fluprostenol in an international trial, for various forms of infertility associated with abnormal persistence of luteal function. These mares were selected for treatment on the basis of clinical examination and 760 (approximately 80 per cent) responded fluprostenol by showing oestrus within s...
Letter: Prostaglandins in the mare.
The Veterinary record    June 5, 1976   Volume 98, Issue 23 471 doi: 10.1136/vr.98.23.471
Fitzpatrick RJ.No abstract available
Letter: Prostaglandins in the mare.
The Veterinary record    May 22, 1976   Volume 98, Issue 21 433 doi: 10.1136/vr.98.21.433
Allen WE, Newcombe JR.No abstract available
Correspondence: Prostaglandins in the mare.
The Veterinary record    May 15, 1976   Volume 98, Issue 20 409 doi: 10.1136/vr.98.20.409-a
No abstract available
Letter: Use of prostaglandins in the mare.
The Veterinary record    May 8, 1976   Volume 98, Issue 19 389-390 doi: 10.1136/vr.98.19.389
Allen WR, Rossdale PD.No abstract available
Luteolysis following carotid or ovarian arterial injection of prostaglandin F2alpha in mares.
Biology of reproduction    May 1, 1976   Volume 14, Issue 4 473-477 doi: 10.1095/biolreprod14.4.473
Douglas RH, Del Campo MR, Ginther OJ.On the day of ovulation (Day 0), 20 pony mares were randomly assigned to one of five groups (4 mares/group) which were given intracarotid arterial (ICA) and intraovarian arterial (IOA) injections on Day 7 as follows: 1) vehicle ICA, vehicle IOA (control); 2) .125 mg PGF2α ICA, vehicle IOA; 3) vehicle ICA, .125 mg PGF2α IOA; 4) .250 mg PGF2α ICA, vehicle IOA; or 5) vehicle ICA, .250 mg PGF2α IOA. Peripheral plasma progesterone and LH concentrations were determined for 0 (pretreatment) and .1, .25, .50, .75, 1, 6, 12, 24, 48, 72 and 96 h posttreatment. The intervals (days) from treatment to ...
Letter: Use of prostaglandins in the mare.
The Veterinary record    April 17, 1976   Volume 98, Issue 16 328 doi: 10.1136/vr.98.16.328
Nelson AM.No abstract available